arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

Grace Therapeutics, Inc.

GRCE

$2.15 ▲ +0.01 (+0.47%) at close

30 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Grace Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -1.9% ↗

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-1.18M

↑ +65.0% —

FCF / Share Free cash flow per share

$-0.13

↑ +33.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
EPS Growth YoY (%)	N/M	61.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	80.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-71.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	55.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-133.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-290.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-440.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-9675.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	16.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	19.1% Good ↑ Good Improving Year-over-year change in net income	-28.5% Weak ↓ Weak Declining Year-over-year change in net income	-28.5% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-3.3% Weak ↓ Weak Declining Year-over-year change in net income	34.9% Excellent ↓ Excellent Declining Year-over-year change in net income	34.9% Excellent ↓ Excellent Declining Year-over-year change in net income	89.1% Excellent ↑ Excellent Improving Year-over-year change in net income	11.1% Fair ↑ Fair Improving Year-over-year change in net income	11.1% Fair ↑ Fair Improving Year-over-year change in net income	11.1% Fair ↑ Fair Improving Year-over-year change in net income	-645.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	30.9% Excellent ↓ Excellent Declining Year-over-year change in net income	33.2% Excellent → Excellent Stable Year-over-year change in net income	33.2% Excellent ↓ Excellent Declining Year-over-year change in net income	33.2% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	47.3% Excellent → Excellent Stable Year-over-year change in net income	47.3% Excellent Excellent Year-over-year change in net income	47.3% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	65.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	60.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-585.6% Weak Weak Year-over-year change in free cash flow	—	—	—	6.3% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	59.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	266.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.9% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.7% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.9% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	23.4% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-4.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.37x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.55x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.11x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.20x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.47x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.96x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Return on Invested Capital (%)	-1.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.0% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-71.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	113.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	651.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-193.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-4.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-4.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-4.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-3.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-3.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-17.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-1.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	-5.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-5.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	1.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-4.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-4.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-5.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-6.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-6.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-42.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-385%)	-4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-3.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-2.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-2.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	-5.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-10.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-18.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-52.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-451%)	-42.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-382%)	127.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+752%)	206.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1275%)	—	-270.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1901%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Net Debt (USD)	$-16.98M	$-18.67M	$-16.86M	$-20.00M	$-22.13M	$-11.05M	$-15.15M	$-19.39M	$-23.00M	$-18.55M	$-26.99M	$-21.63M	$-27.88M	$-26.24M	$-34.93M	$-38.38M	$-30.34M	$-33.01M	$-36.93M	—	$-50.94M	$-26.55M	$-11.55M	$-12.12M	$-14.24M	—	—	—	$-6.42M	—

📊 What does each share earn? 5 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-0.06	$-0.14	$-0.06	$-0.21	$0.10	$-0.36	$-0.30	$-0.24	$-0.26	$-0.21	$-0.43	$-0.54	$-3.91	$-0.09	$-0.11	$-0.10	$-0.04	—	—	$-0.12	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.13	$-0.20	$-0.11	—	—	—	$-0.33	—	—	—	$-0.84	—	—	—	$-0.12	—	—	—	$-0.13	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	—	$4.19	$4.45	$4.60	—	$5.14	$4.88	$5.43	—	$5.62	$8.84	$8.61	$9.14	$2.17	$2.25	$2.36	$2.44	—	—	$2.05	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	—	$1.01	$0.96	$1.03	—	$0.28	$0.60	$0.92	—	$1.34	$2.31	$1.98	$2.51	$0.31	$0.39	$0.49	$0.58	—	—	$2.05	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	16.93M	15.92M	15.92M	—	11.51M	11.51M	10.93M	—	11.51M	7.55M	7.44M	—	44.61M	44.55M	44.33M	—	—	—	26.05M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Working Capital (USD)	$15.23M	$17.93M	$16.05M	$18.21M	$20.78M	$9.97M	$13.39M	$17.83M	$22.33M	$25.11M	$27.49M	$21.65M	$25.88M	$30.00M	$33.70M	$37.54M	$42.02M	$46.10M	$50.07M	—	$60.79M	$27.95M	$9.96M	$7.99M	$11.07M	—	—	—	$14.30M	—
Total Equity (USD)	$63.90M	$64.89M	$62.82M	$63.55M	$66.61M	$52.14M	$56.13M	$59.36M	$61.74M	$64.68M	$66.75M	$64.01M	$67.95M	$96.72M	$100.16M	$104.40M	$108.27M	$111.06M	$114.20M	$53.46M	$55.66M	$25.71M	$8.87M	$11.04M	$12.99M	$-4.29M	$-759.00K	$3.27M	$11.04M	$7.19M

📋 What is driving earnings? 4 metrics

Metric	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2021 10-Q ↗	Q2 FY2022 Sep 30, 2021 10-Q ↗	Q1 FY2022 Jun 30, 2021 10-Q ↗	Q4 FY2021 Mar 31, 2021 10-K ↗	Q3 FY2021 Dec 31, 2020 10-Q ↗	Q2 FY2021 Sep 30, 2020 10-Q ↗	Q1 FY2021 Jun 30, 2020 10-Q ↗	Q4 FY2020 Mar 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2019 10-Q ↗	Q2 FY2020 Sep 30, 2019 10-Q ↗	Q1 FY2020 Jun 30, 2019 10-Q ↗	Q4 FY2019 Mar 31, 2019 10-K ↗	Q4 FY2018 Mar 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	—	$81.00K	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.00K	$3.00K	$0.00	$2.00K	$2.00K	—	—	$1.00K	$1.00K	—	—	$7.00K	$8.00K	—	—	$167.00K	$0.00	$0.00	$0.00	$0.00	$1.00K	—	$56.00K	$86.00K	$139.00K	$110.00K	$72.00K	$89.00K	—	—
Net Income, GAAP (USD)	$-1.18M	$-3.36M	$-3.36M	$-3.36M	$636.00K	$-4.16M	$-2.62M	$-2.62M	$-3.17M	$-4.02M	$-4.02M	$-4.02M	$-29.09M	$-4.52M	$-4.52M	$-4.52M	$-3.90M	$-3.12M	$-3.12M	$-3.12M	$-5.65M	$-4.67M	$-4.67M	$-4.67M	$16.61M	$-8.85M	$-8.85M	$-8.85M	—	—
Operating Cash Flow (USD)	$-1.70M	$-2.23M	$-3.14M	$-1.80M	$-2.95M	—	—	$-3.60M	$-2.09M	—	—	$-6.24M	$-3.33M	—	—	$-5.43M	$-3.15M	$-4.58M	$-6.10M	$-3.40M	$-1.76M	$-4.21M	$-4.18M	$-4.31M	$-2.90M	$-7.10M	$-6.15M	$-6.82M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 30 quarters

Grace Therapeutics, Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GRCE with peers